Phase I trial of AKB 9778 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2012
At a glance
- Drugs AKB 9778 (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Pharmacokinetics
- 20 Mar 2012 Positive safety, pharmacokinetic and pharmacodynamic results were reported in an Aerpio media release
- 20 Mar 2012 Status changed from recruiting to completed, according to an Aerpio media release.
- 13 Jan 2012 New trial record